Vista Investment Management’s AbbVie ABBV Stock Holding History

Vista Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$306K	Hold	1,217	–	–	0.09%	154
2026 Q1	$265K	Hold	1,217	–	–	0.09%	157
2025 Q4	$278K	Sell	1,217 -20	-2%	-$4.56K	0.09%	153
2025 Q3	$286K	Hold	1,237	–	–	0.1%	150
2025 Q2	$230K	Hold	1,237	–	–	0.09%	161
2025 Q1	$259K	Sell	1,237 -295	-19%	-$57.3K	0.1%	156
2024 Q4	$272K	Sell	1,532 -175	-10%	-$32.2K	0.1%	155
2024 Q3	$337K	Sell	1,707 -6	-0.4%	-$1.12K	0.13%	142
2024 Q2	$294K	Buy	1,713 +175	+11%	+$29K	0.12%	145
2024 Q1	$280K	Sell	1,538 -67	-4%	-$11.5K	0.11%	151
2023 Q4	$249K	Sell	1,605 -400	-20%	-$58.3K	0.12%	151
2023 Q3	$299K	Hold	2,005	–	–	0.16%	130
2023 Q2	$270K	Buy	2,005 +400	+25%	+$58.7K	0.14%	145
2023 Q1	$256K	Sell	1,605 -150	-9%	-$22.9K	0.14%	141
2022 Q4	$284K	Sell	1,755 -101	-5%	-$15.5K	0.16%	132
2022 Q3	$249K	Buy	1,856 +100	+6%	+$14.3K	0.15%	138
2022 Q2	$269K	Hold	1,756	–	–	0.16%	135
2022 Q1	$285K	Hold	1,756	–	–	0.16%	139
2021 Q4	$238K	Buy	+1,756	New	+$207K	0.13%	153

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Vista Investment Management's ABBV Position: Q2 2026 in Review

Vista Investment Management held its AbbVie (ABBV) position steady in Q2 2026 at 1,217 shares worth $306K. The position accounts for 0.09% of the portfolio, ranked #154.

Vista Investment Management first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. The position peaked at $337K in Q3 2024. 4,190 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Vista Investment Management held 1,217 shares of AbbVie worth $306K as of Q2 2026.
Vista Investment Management left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 0.09% of Vista Investment Management's portfolio in Q2 2026, its #154 holding.
Vista Investment Management first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
Vista Investment Management's AbbVie position peaked at $337K in Q3 2024.
4,190 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Vista Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.